[go: up one dir, main page]

GB201710496D0 - Dosage regime - Google Patents

Dosage regime

Info

Publication number
GB201710496D0
GB201710496D0 GBGB1710496.9A GB201710496A GB201710496D0 GB 201710496 D0 GB201710496 D0 GB 201710496D0 GB 201710496 A GB201710496 A GB 201710496A GB 201710496 D0 GB201710496 D0 GB 201710496D0
Authority
GB
United Kingdom
Prior art keywords
dosage regime
regime
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1710496.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
Medlmmune Ltd
Original Assignee
ADC Therapeutics SA
Medlmmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, Medlmmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1710496.9A priority Critical patent/GB201710496D0/en
Publication of GB201710496D0 publication Critical patent/GB201710496D0/en
Priority to JP2019569364A priority patent/JP2020523384A/en
Priority to EP18732040.3A priority patent/EP3638372A1/en
Priority to CA3064681A priority patent/CA3064681A1/en
Priority to PCT/EP2018/065862 priority patent/WO2018229218A1/en
Priority to KR1020207001219A priority patent/KR20200028950A/en
Priority to MX2019014923A priority patent/MX2019014923A/en
Priority to BR112019026498-1A priority patent/BR112019026498A2/en
Priority to US16/622,663 priority patent/US11426467B2/en
Priority to AU2018285455A priority patent/AU2018285455A1/en
Priority to US17/812,950 priority patent/US20230039868A1/en
Ceased legal-status Critical Current

Links

GBGB1710496.9A 2017-06-14 2017-06-30 Dosage regime Ceased GB201710496D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1710496.9A GB201710496D0 (en) 2017-06-30 2017-06-30 Dosage regime
AU2018285455A AU2018285455A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-CD25 ADC
PCT/EP2018/065862 WO2018229218A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd25 adc
EP18732040.3A EP3638372A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd25 adc
CA3064681A CA3064681A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd25 adc
JP2019569364A JP2020523384A (en) 2017-06-14 2018-06-14 Dosing regimen for administering anti-CD25 ADC
KR1020207001219A KR20200028950A (en) 2017-06-14 2018-06-14 Dosage regime for administration of anti-CD25 ADC
MX2019014923A MX2019014923A (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd25 adc.
BR112019026498-1A BR112019026498A2 (en) 2017-06-14 2018-06-14 dosing regimens for administration of an anti-cd25 adc
US16/622,663 US11426467B2 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-CD25 ADC
US17/812,950 US20230039868A1 (en) 2017-06-14 2022-07-15 Dosage regimes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1710496.9A GB201710496D0 (en) 2017-06-30 2017-06-30 Dosage regime

Publications (1)

Publication Number Publication Date
GB201710496D0 true GB201710496D0 (en) 2017-08-16

Family

ID=59592347

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1710496.9A Ceased GB201710496D0 (en) 2017-06-14 2017-06-30 Dosage regime

Country Status (1)

Country Link
GB (1) GB201710496D0 (en)

Similar Documents

Publication Publication Date Title
EP3638658C0 (en) Pharmaceutical compounds
PL3484451T3 (en) Dosage form
GB201704714D0 (en) Pharmaceutical compounds
GB201703876D0 (en) Pharmaceutical combinations
GB201704965D0 (en) Pharmaceutical compounds
GB201703881D0 (en) Pharmaceutical compounds
GB201713653D0 (en) Dosage regimen
IL269239A (en) Pharmaceutical combination comprising ponesimod
GB201521217D0 (en) Dosage regimens
GB201706806D0 (en) Pharmaceutical compounds
GB201711704D0 (en) Pharmaceutical compounds
HRP20220427T8 (en) Pharmaceutical compounds
GB201704966D0 (en) Pharmaceutical compounds
GB201607548D0 (en) Solid dosage form
IL249374A0 (en) Pharmaceutical dosage forms
PT3866775T (en) Dosage regime
GB201720544D0 (en) Dosage regime
GB201720541D0 (en) Dosage regime
GB201720542D0 (en) Dosage regime
GB201720543D0 (en) Dosage regime
GB201710496D0 (en) Dosage regime
GB201710493D0 (en) Dosage regime
GB201710494D0 (en) Dosage regime
GB201710495D0 (en) Dosage regime
GB201709439D0 (en) Dosage regime

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)